Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples